SEC Form 4 · accession 0001493152-18-006355
ONCOSEC MEDICAL Inc · ONCS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel J. O'Connor
Officer — Chief Executive Officer · Director
Period of report
May 3, 2018
Accepted (ET)
May 7, 2018 · 5:23 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001444307
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1,F2 | $1.47 | May 3, 2018 | A | 250,000 | A | May 3, 2018 | May 3, 2028 | Common Stock | 250,000 | 2,850,000 | D |
Explanation of responses
- F1OncoSec's (ONCS) stock closing price was $1.47 on May 3, 2018.
- F225% vested on the Grant Date of May 3, 2018, and the remaining 75% are vesting in 36 equal monthly increments, which began on the first monthly anniversary of the Grant Date, pursuant to the OncoSec Medical Incorporated 2011 Stock Incentive Plan.